Where the margin actually sits in AI compute.
Hyperscaler capex peaked. Inference economics shifted. We mapped who survives the next 18 months and who's refinancing their datacenter.
Hyperscaler capex peaked. Inference economics shifted. We mapped who survives the next 18 months and who's refinancing their datacenter.
Hyperscaler capex peaked. Inference economics shifted. We mapped who survives the next 18 months and who's refinancing their datacenter.
$280B of TAM still runs on Excel. We profiled 14 industries where vertical SaaS compounds at 90%+ NRR — and the 3 where it doesn't.
The investable robotics story is mixed-fleet logistics, not Atlas demos. Our thesis on what actually makes money.
Anduril, Shield, Palantir — the new triad. Procurement velocity, contract structure, and where the 10x price-performance pockets are still un-traded.
Why the first commercial quantum revenue lands in materials and pharma — and the three companies positioned to convert from grant-funded research into recurring license revenue by 2028.
AlphaFold-class models hit a data wall. The next compounder is wet-lab + sequencing combined data flywheels. Six private companies and one public moat we're long.
AI buildouts tied $98B of capex to long-dated PPAs. We map the merchant generators, the transmission bottlenecks, and which utility plays got mispriced as 'boring infra.'
The volume migrated from speculation to settlement. We profile the issuers, the on-ramps, and the corporate treasuries quietly running on USDC payment rails.
Coverage is published quarterly. Access is granted to allocators, portfolio companies, and operators with a working thesis in the relevant sector. Briefings and Q&A calls are included with active subscriptions.